<DOC>
	<DOCNO>NCT00693589</DOCNO>
	<brief_summary>Endothelial dysfunction early marker atherosclerosis find patient ( pt ) coronary ( CAD ) peripheral artery disease ( PAD ) . Statin-therapy show improve endothelial function pt CAD PAD reduce LDL-cholesterol inflammatory marker . B-group vitamin-supplements variable report positive neutral effect endothelial function . Therefore , want compare effect rosuvastatin B-group vitamin supplementation endothelial function forearm resistance vessel pts cardiovascular disease .</brief_summary>
	<brief_title>Effect Homocysteine-Lowering Therapy With Folic Acid , Vitamin B12 , Vitamin B6 Endothelium-Dependent Vasodilatation Forearm Resistance Vessels Patients With Coronary Heart Disease</brief_title>
	<detailed_description>Study design : 36 pt CAD PAD randomly assign either rosuvastatin 10mg/d vitamin supplementation folic acid 1mg , vitamin B12 0.4mg B6 10mg/d 6 week double-blinded design . After 6 week pts receive rosuvastatin vitamin supplementation combination additional 6 week .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>CAD PAD ( &gt; 50 % luminal stenosis ) , previous myocardial infarction bypass surgery &gt; 3 month ago history percutaneous coronary intervention ( PTCA stenting ) confirm consent myocardial infarction acute coronary syndrome bypass surgery &lt; 3 month ago ongoing treatment statin ongoing vitamin supplementation folic acid B vitamins &lt; 18 year active smoker uncontrolled arterial hypertension renal insufficiency atrial fibrillation liver disease NYHA class &gt; 2 familial hypercholesterolemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>flow mediate dilatation</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>folic acid</keyword>
	<keyword>B vitamin</keyword>
</DOC>